Long-lasting benefit on multimodal treatment combining osimertinib and stereotaxic radiotherapy for metastatic non-small cell lung cancer with the EGFR exon 20 insertion 773-774 HVdelinsLM: a case report

A non-small-cell-lung-cancer patient with cerebral metastasis presenting an atypical exon 20 mutation in the EGFR gene had a long-lasting tumor cotrol on mulimodal treatment with osimertinib and stereotaxic radiotherapy on oligoprogressing lesions. Most exon-20 mutations are resistant to first, seco...

Descripción completa

Detalles Bibliográficos
Autores principales: Louvet, Aurélie, Honoré, Natasha, Dekairelle, Anne-France, Van Marcke, Cédric, Goeminne, Jean-Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350683/
https://www.ncbi.nlm.nih.gov/pubmed/37465107
http://dx.doi.org/10.3389/fonc.2023.1143775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350683/
https://www.ncbi.nlm.nih.gov/pubmed/37465107
http://dx.doi.org/10.3389/fonc.2023.1143775

Ejemplares similares